Healing Centers Program

Research to understand the outcomes, impact, and participant journey of psychedelic and dissociative treatments for mental health.

 

Your participation in this study could help shape treatment possibilities for patients in the future.

 

• - Seeking patients who are entering ketamine or esketamine treatment
• - Collecting information through a series of surveys
• - Investigating safety and effectiveness of psychedelic and dissociative treatment for
•   mental health disorders
•  
•  

Compensation Provided

We are gathering information through a series of surveys from patients entering treatment with ketamine or esketamine.

We'll ask about who you are, such as your age, background, and medical history. 

We'll also ask about your experience in treatment and your mental health before and after treatment to see if there are changes in your symptoms and your overall wellbeing.

 

Duration of Participation

You will be asked to fill out 9 surveys over the next 12-14 months.
Each survey will take approximately 15 minutes.
 

Compensation provided throughout the full study term.

We appreciate your interest in participating in research to understand your experiences with psychedelics.

This study has been approved by COMIRB under IRB 23-2229. You can contact the principal investigator, Dr. Andrew Monte, by email at Andrew.Monte@rmpds.org or by phone at 303-389-1100. You may also contact the program team at healingcenters@dhha.org.

Research sponsored by Denver Health & Hospital Authority.